|Articles|December 30, 2022
Calyx Acquired by CapVest/GLO Healthcare
The financial transaction details pertaining to the eClinical technology provider's deal were not disclosed.
Advertisement
GLO Healthcare, a healthcare platform created by private equity investor CapVest Partners LLP, has completed the acquisition of Calyx, an software and services provider of medical imaging, IRT, CTMS, RIM and EDC for the clinical trials industry. The terms of the transaction are not being disclosed. Calyx will join GLO’s development and delivery of diagnostic testing for major cancers and other diseases.
Read more about
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial
2
ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation
3
ACT Brief: Simplifying Trials Through Selective Safety Data, AI-Driven Site Partnerships, and Biopharma Strategic Pivots
4
AI-Enabled Systems Medicine: From Digital Promise to Clinical Operating Model
5